Gastric cancer

New gastric cancer insights come to light with the help of powerful single-cell technologies.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

The Epstein-Barr virus can cause epigenetic changes that persist even after the infection has been cleared, highlighting why prevention is better than cure when it comes to gastric cancer.

A*STAR scientists have uncovered a novel surface marker that identifies stem cells and potential cancer stem cells in the distal stomach.

Genetic and epigenetic testing of samples from people with cellular changes to the stomach lining could help predict their risk of developing cancer

Machine learning helps locate dozens of mutations statistically linked to gastric cancer in non-coding DNA regions

Stem cell reserves found in the stomach have
implications for the genesis of gastric cancer

Diagnostic tests are the key to the early detection and treatment of
diseases — and Singapore’s Diagnostics Development (DxD) Hub is accelerating the rate at which devices make it from the lab to market.

Alterations in gene
regulation make gastric cancer cells less visible to the immune system

First roadmap of stomach cancer super-enhancers paves the way for new treatments.

Stem cell behavior revealed by a combination of modeling and microscopy

The genetic signatures of gastric cancer cell lines reveal disease subtypes with different drug sensitivities